Académique Documents
Professionnel Documents
Culture Documents
The meshes are also sometimes offered as a treatment for women suffering from pelvic organ
prolapse. Pelvic organ prolapse affects up to half of women who have had children, and occurs
when a pelvic organ – such as the bladder, rectum or uterus – “sags” and moves out of place.
This can happen when the pelvic floor muscles, ligaments and tissue that hold the organs in
place are weak or damaged.
Childbirth is a main source of trauma to the muscles and ligaments, and hormonal changes
during the menopause also lead to muscles weakening and becoming less elastic. Heavy lifting
can also cause damage to the pelvic organs and lead to prolapse. The condition also tends to
run in families and is more common in women who are overweight.
While some women have no symptoms, pelvic organ prolapse can be debilitating and make it
hard to go to the toilet, can cause painful or heavy sensations in the vagina, and can make sex
difficult, all of which require treatment. It can also cause a loss of sensation and make it harder
to “push”, for example when urinating. For women with these symptoms reconstructive surgery
using vaginal mesh is sometimes recommended.
12/23/2017 What does pelvic mesh do and why are women suing over it? – explainer | Society | The Guardian
Read more
The aim of the mesh is to give permanent support to the weakened organs and to repair
damaged tissue.
Surgery can be done through the abdomen (transabdominal) or through the vagina
(transvaginal). A small incision is made in the vaginal or abdominal wall, and the surgical mesh is
implanted and held in place by sutures or tissue fixation devices. The idea is that tissue will grow
into the pores of the mesh to create a wall of support.
Early clinical trials suggested excellent efficacy and many surgeons saw advantages over
traditional open-surgery procedures, which took longer to perform, involved a longer recovery
for patients and were associated with their own range of complications. By contrast, a TVT
procedure typically takes 3o minutes, is performed using keyhole surgery and patients often go
home the same day.
Meanwhile, the traditional treatments for pelvic organ prolapse, which included suturing to
reconstruct and repair the affected organs and surrounding tissue, were proving less successful,
with reports of up to 29% of women suffering another prolapse after treatment. Hysterectomy is
another treatment option, which some women wish to avoid.
Read more
12/23/2017 What does pelvic mesh do and why are women suing over it? – explainer | Society | The Guardian
“Because outcomes of using the mesh for incontinence and hernia were so good people were
enthusiastic and confident it would also be good for prolapse,” said Christopher Maher, a
urogynaecologist and associate professor at the University of Queensland. “That’s what the
mindset was when it was introduced for prolapse around 2002.”
But he said regulators around the world should have demanded more testing to ensure the
mesh was as effective for treating prolapse as it was for other conditions.
There have also been reports that pharmaceutical companies who make the meshes began
heavily promoting them to doctors for treating pelvic organ prolapse. By 2010, transvaginal
mesh operations accounted for nearly 25% of prolapse interventions in some countries.
There is also little robust information on the success of the procedures in the long term and
when carried out in the wider population. However, there are indications that complication rates
could be significantly higher than those typically reported in trials – in the UK, NHS data
suggests that one in 15 women later has to have their implant surgically removed.
In a survey of 2,220 women who had undergone pelvic mesh implants to treat stress urinary
incontinence and pelvic organ prolapse, 59% said the procedure did not resolve their original
issue, and 58% said they were left experiencing pain during intercourse. However, this was a
consumer survey, carried out by the consumer advocacy group, the Health Issues Centre, rather
than being a scientific study.
As the mesh became more widely used, women came forward suffering complications and class
actions have been brought against manufacturers around the world. In 2012 the United States
Food and Drug Administration reclassified transvaginal mesh as a high-risk device.
These include mesh exposure and erosion – when the mesh pokes through the vaginal wall or
cuts through internal tissue – vaginal scarring, fistula formation, painful sex, and pelvic, back and
leg pains. Some of these complications may occur years after surgery and can be difficult to
treat. And although serious complications appear to be rare, given the thousands of women who
have had the implants, the numbers of women suffering adverse reactions is high.
Three Johnson & Johnson group companies are now fighting a major class action from 700
Australian women, who allege faulty pelvic mesh implants caused them debilitating pain. Similar
class actions involving thousands of women are also under way in the UK and US. More than
12/23/2017 What does pelvic mesh do and why are women suing over it? – explainer | Society | The Guardian
100,000 transvaginal mesh lawsuits have been filed in the US, with the manufacturer of the most
commonly used meshes, Johnson & Johnson, facing the most lawsuits.
Read more
In many of the cases, issues have been raised around informed consent. Shine Lawyers is leading
the Australian class action and alleges Johnson & Johnson failed to properly test the devices and
played down their risk to both surgeons and patients.
The Australian government is also holding a Senate inquiry into the use of transvaginal mesh
examining any financial or other incentives provided to medical practitioners to use or promote
transvaginal mesh implants, the lack of data available on how many procedures were performed,
and the type and incidence of health problems women have experienced. The next round of
public hearings will be held in Sydney on 18 September.
Advertisement
In the US, the Food and Drug Administration [FDA] issued safety warnings to doctors and
consumers in 2011 about an increase in adverse event reports related to mesh. The latest
available FDA figures show approximately 300,000 women in the US undergo surgical
procedures for prolapse each year and approximately 260,000 underwent surgical procedures to
repair stress incontinence. According to industry estimates, approximately one out of three
prolapse surgeries used mesh, and of the incontinence surgeries, over 80% were done
transvaginally with mesh.
There is no accurate data available to track the number of women who have had a mesh implant
for the treatment of prolapse or incontinence in Australia, Higgs says.
According to Maher, this is because surgeries for prolapse have been recorded under “vaginal
repair”, which can involve numerous procedures that do not involve mesh. It also makes it hard
to determine complication rates related to mesh unless women are signed up to clinical trials.
12/23/2017 What does pelvic mesh do and why are women suing over it? – explainer | Society | The Guardian
However, Australia’s Therapeutic Goods Administration believes there have been “many
thousands” of mesh devices implanted in Australian patients.
Read more
Brands of mesh have been pulled from the market around the world by manufacturers, and
brands and types that have been studied have been replaced by newer versions that doctors
have less evidence about. This makes it difficult to understand if some have higher complication
rates or are more effective than others.
Advertisement
“However, some women might experience a late vaginal mesh exposure or erosion,” she said. “If
women are concerned, or experience any abnormal vaginal bleeding or pain, we encourage you
to see your doctor.”
The complications seem to be much more common in women who had the surgery to treat
prolapse.
While new treatments are sometimes trialled on patients when other options have proven
ineffective, patients should always be informed that the treatment is new and that little data
exists for its efficacy, so that they can give informed consent. Women should feel comfortable
asking their specialist about complication rates, the evidence that the surgery will work, and
about surgeon training.